Oxygen delivery: Implications for the biology and therapy of solid tumors

Oncology Research

Volumn 9, Issue 6-7, 1997, Pages 383-390

  Rockwell, Sara ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chemotherapy; Microenvironmental heterogeneity; Oxygen delivery; Radiotherapy; Tumor oxyg nation; Tumor vascularization

Indexed keywords

ANTINEOPLASTIC AGENT; OXYGEN; RADIOSENSITIZING AGENT;

CLINICAL TRIAL; DRUG POTENTIATION; HUMAN; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; REVIEW;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DRUG SYNERGISM; HUMANS; NEOPLASMS; OXYGEN; RADIATION-SENSITIZING AGENTS;

EID: 0031307796     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Gray, L. H.; Conger, A. D.; Eben, M.; Hornsey, S.; Scott, O. C. A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 26:638-648; 1953.
2. Gray, L. H. Radiobiologie basis of oxygen as a modifying factor in radiation therapy. Am. J. Roentgenol. 85:803-815; 1961.
3. Quintiliani, M. The oxygen effect in radiation inactivation of DNA and enzymes. Int. J. Radiât. Biol. 50:573-594; 1986.
4. Thomlinson, R. H.; Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J Cancer 11:539-548; 1955.
5. Suit, H. D.; Maeda, M. Hyperbaric oxygen and radiobiology of a C3H mouse mammary carcinoma. J. Natl. Cancer Inst. 39:639-652; 1967.
6. Fowler, J. R. LaRonde -radiation sciences and medical radiology. Radiother. Oncol. 1:1-22; 1983.
7. Suit, H. D. Modification of radiation response. Int. J. Radial. Oncol. Biol. Phys. 10:101-108; 1984.
8. Moulder, J. E.; Rockwell, S. Hypoxie fractions of solid tumors: Experimental techniques, methods of analysis, and a
9. survey of existing data. Int. J. Radiât. Oncol. Biol. Phys. 10: 695-712; 1984.
10. Moulder, J. E.; Rockwell, S. Tumor hypoxia: Its impact on cancer therapy. Cancer Metastasis Rev. 5:313-341; 1987.
11. Rockwell, S.; Moulder, J. E. Hypoxie fractions of human tumors xenografted into mice: A review. Int. J. Radiât. Oncol. Biol. Phys. 19:197-202; 1990.
12. Moulder, J. E.; Dutreix, J.; Rockwell, S.; Siemann, D. W. Applicability of animal tumor data to cancer therapy in humans. Int. J. Radiât. Oncol. Biol. Phys. 14:913-927; 1988.
13. Whalen, R. E.; Saltzman, H. A.; Holloway, D. H.; Mclntosh, H. D.; Sieker, H. O.; Brown, I. W. Cardiovascular and blood gas responses to hyperbaric oxygénation. Am. J. Cardiol. 15: 638-646; 1965.
14. Bunn, H. F.; Forget, B. G. Hemoglobin: Molecular, genetic, and clinical aspects. Philadelphia: W. B. Saunders Co.; 1986.
15. Fischer, J. J.; Rockwell, S.; Martin, D. F. Perfluorochemicals and hyperbaric oxygen in radiation therapy. Int. J. Radial. Oncol. Biol. Phys. 12:95-102; 1986.
16. Tannock, I. F. Oxygen diffusion and the distribution of cellular radiosensitivity in tumours. Br. J. Radiol. 45:515-524; 1972.
17. Grau, C.; Horsman, M. R.; Overgaard, J. Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing. Int. J. Radiât. Oncol. Biol. Phys. 22:415-419; 1992.
18. Overgaard, J.; Horsman, M. R. Modification of hypoxiainduced radioresistance in tumors by the use of oxygen and sensitizers. Semin. Radiât. Oncol. 6:10-21; 1996.
19. Hirst, D. G.; Hazlehurst, J. L.; Brown, J. M. The effect of hematocrit on tumour sensitivity to x-rays. Int. J. Radiât. Biol. 46:345-354; 1984.
20. Sevick, E. M.; Jain, R. K. Viscous resistance to blood flow in solid tumors: Effect of hematocrit on intratumor blood viscosity. Cancer Res. 49:3513-3519; 1989.
21. Hirst, D. G.; Wood, P. J. The adaptive response of mouse tumours to anaemia and retransfusion. Int. J. Radiât. Biol. 51:597-609; 1987.
22. Dusenbery, K. E.; McGuire, W. A.; Holt, P. J.; Carson, L. F.; Fowler, J. M.; Twiggs, L. B.; Polish, R. A. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. Int. J. Radial. Oncol. Biol. Phys. 29:1079-1084;1994.
23. Chang, T. M. S.; Geyer, R., Ill International Symposium on "Blood Substitutes." Biomater. Artif. Cells Artif. Organs 16: 1-703; 1988.
24. Teicher, B. A.; Ara, G.; Chen, Y-n.; Emi, Y.; Kakeji, Y.; Ikebe, M.; Maehara, Y. PEG-hemoglobin: Effects on tumor oxygénation and radiosensitization. Radiât. Oncol. Invest. 4: 200-210; 1996.
25. Ingermann, R. L. Physiological significance of Root effect hemoglobins in trout. Respir. Physiol. 49:1-10; 1982.
26. Brittain, T. The Root effect. Comp. Biochem. Physiol. 86: 473-481;1987.
27. Wike-Hooley, J. L.; Haveman, J.; Reinhold, H. S. The relevance of tumor pH to the treatment of malignant disease. Radiother. Oncol. 2:343-366; 1984.
28. Teicher, B. A.; Herman, T. S.; Frei, E., 3rd. Perfluorochemical emulsions: Oxygen breathing in radiation sensitization and chemotherapy modulation. Important Adv. Oncol. 39-59; 1992.
29. Rockwell, S. Perfluorochemical emulsions and radiation therapy. Artif. Cells Blood Substit. Immobil. Biotechnol. 22: 1097-1108;1994.
30. Martin, D. F.; Porter, E. A.; Fischer, J. J.; Rockwell, S. Effect of a perfluorochemical emulsion on the radiation response of BA1112 rhabdomyosarcomas. Radiât. Res. 112:4553; 1987.
31. Hirst, D. G.; Wood, P. J.; Schwanz, H. C. The modification of hemoglobin affinity for oxygen and tumor radiosensitivity by antilipidemic drugs. Radiât. Res. 112:164-172; 1987.
32. Khandelwal, S. R.; Lin, P-S.; Hall, C. E.; Truong, Q. T.; Lu, J.; Laurent, J. J.; Joshi, G. S.; Abraham, D. J.; Schmidt-
33. Ullrich, R. K. Increased radiation response of FSall fibrosarcomas in C3H mice following administration of an allosteric effector of hemoglobin-oxygen affinity. Radial. Oncol. Invest. 4:51-59; 1996.
34. Haffty, B. G.; Son, Y. H.; Papac, R.; Sasaki, C. T.; Weissberg, J. B.; Fischer, D.; Rockwell, S.; Sartorelli, A. C.; Fischer, J. J. Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale mitomycin randomized trials. J. Clin. Oncol. 15:268-276; 1997.
35. Höckel, M.; Knoop, C.; Schlenger, K.; Vorndran, B.; Knapstein, P. G.; Vaupel, P. Intra-tumor pO> histography as predictive assay in advanced cancer of the uterine cervix. Adv. Exp. Med. Biol. 345:445-450; 1994.
36. Nordsmark, M.; Bentzen, S. M.; Overgaard, J. Measurement of human tumour oxygénation status by a polarographic needle electrode: An analysis of inter-and intratumour heterogeneity. Ada Oncol. 33:383-389; 1994.
37. Brizel, D. M.; Scully, S. P.; Harrelson, J. M.; Layfield, L. J.; Bean, J. M.; Prosnitz, L. R.; Dewhirst, M. W. Tumor oxygénation predicts for the likelihood of distant métastases in human soft tissue sarcoma. Cancer Res. 56:941-943; 1996.
38. Knighton, D. R.; Hunt, T. K.; Scheuenstuhl, H.; Halliday, B. J.; Werb, Z.; Banda, M. J. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221:1283-1285; 1983.
39. Shweiki, D.; hin, A.; Soffer, D.; Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845; 1992.
40. Rockwell, S.; Knisely, J. P. S. Hypoxia and angiogenesis in experimental tumor models: Therapeutic implications. In: Goldberg, I. D.; Rosen, E. M., eds. Regulation of angiogenesis. Basel, Switzerland: Birkhauser Verlag; 1996:335-356.
41. Weidner, N.; Semple, J. P.; Welch, W. R.; Folkman, J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1-8; 1991.
42. Reynolds, T. Y.; Rockwell, S.; Glazer, P. M. Genetic instability induced by tumor microenvironment. Cancer Res. 56: 5754-5757; 1996.
43. Graeber, T. G.; Osmanian, C.; Jacks, T.; Housman, D. E.; Koch, C. J.; Lowe, S. W.; Giaccia, A. J. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumors. Nature 379:89-91; 1996.
44. Rice, G. C.; Hoy, C.; Schimke, R. T. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. USA 83:5978-5982; 1986.
45. Young, S. D.; Marshall, R. S.; Hill, R. P. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc. Natl. Acad. Sci. USA 85:9533-9537; 1988.
46. Young, S. D.; Hill, R. P. Effects of reoxygenation on cells from hypoxic regions of solid tumors: Anticancer drug sensitivity and metastatic potential. J. Natl. Cancer Inst. 82:371-380; 1990.
47. Teicher, B. A.; Lazo, J. S.; Sartorelli, A. C. Classification of antineoplastic agents by their selective toxicities towards oxygenated and hypoxic tumor cells. Cancer Res. 41:73-81; 1981.
48. Simpson-Herren, L.; Noker, P. E. Diversity of penetration of anti-cancer agents into solid tumours. Cell Prolif. 24:355-365; 1991.
49. Teicher, B. A. Physiologic mechanisms of therapeutic resistance. Blood flow and hypoxia. Hematol. Oncol. Clin. North Am. 9:475-506; 1995.
50. Rockwell, S. Hypoxia directed drugs: Use with irradiation. In: Rosenthal, C. J., ed. Infusion chemotherapy-radiation interaction. New York: Elsevier Publishing Co. (in press).
51. Brown, J. M.; Giaccia, A. J. Tumor hypoxia: The picture has changed in the 1990s. Int. J. Radiât. Biol. 65:95-102; 1994.
52. Rockwell, S. Use of hypoxia-directed drugs in the therapy of solid tumors. Semin. Oncol. 19:29-40; 1992.